author-photo

Peter A. Charlton

19

Papers

247

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Molecular chess? Hallmarks of anti-cancer drug resistance

2017 BMC Cancer
- Ian A. Cree
- Peter A. Charlton
Show All
- Source
- Cite
- Save
Citations (128)
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation

2013 Strahlentherapie Und Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Reversal of P-Glycoprotein Mediated Multidrug Resistance by Novel Anthranilamide Derivatives.

2010 ChemInform
Show All
- Source
- Cite
- Save
Citations (0)
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples

2004 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (15)
Ex vivo reversal of chemoresistance by tariquidar (XR9576).

2004 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (21)
Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors.

2004 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (8)
Ex vivo activity of two novel dual topoisomerase I and II inhibitors XR5944 and XR11576 against soli

2001
Show All
- Source
- Cite
- Save
Citations (0)
Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.

2000 Clinical & Experimental Metastasis
Show All
- Source
- Cite
- Save
Citations (36)
Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits

1997 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Atrial natriuretic factor in the Langendorff perfused coronary vasculature of the rabbit isolated heart

1989 Life Sciences
Show All
- Source
- Cite
- Save
Citations (0)